Latest Announcements & Industry Updates
Stay informed with the latest milestones, regulatory updates, and technological advancements from Incepbio®.
Latest Updates
Incepbio Exhibiting at Malaysia Pharma & Healthcare Expo2026
Join our CQV and digital compliance experts at Stall 4059, KLCC. Discover how we're transforming pharmaceutical validation in Southeast Asia.
IncepBio at Pharma Microbiology & CCS Event2026
Meet IncepBio's CEO Prashanth Hugar at the Pharma Microbiology & CCS Congress 2026 in Ahmedabad. We provide end-to-end cleanroom engineering, validation, and contamination control — solutions.
Introducing Incepone: The Next-Gen Digital Compliance Platform
We are thrilled to launch IncepOne a unified cloud-based platform designed to — streamline paperless validation and asset lifecycle management.
Recognized as Top Validation Service Provider2026
Incepbio® has been recognized by PharmaTech Outlook as a top 10 provider for — commissioning, qualification, and validation services globally.
Deadline
Johnson Smith
The Best
Contents
Own Way To Success
The Dream
A Reality
Dolor Sit
Dolor Sit
To Rid To Dolor
Sit Lorem
A Year of Breakthroughs
Malaysia Pharma Expo 2026
Incepbio made a significant impact at the Malaysia Pharma & Healthcare Expo this year, showcasing our latest digital compliance platform, Incepone. The event provided a fantastic opportunity to connect with industry leaders.
"Connecting with partners and clients on a global stage helps us drive innovation in pharmaceutical validation."
Symbosia Excellence Award
We are honored to receive the Symbosia Award for our outstanding contributions to quality and compliance in the life sciences sector.
Expanding Horizons
Our global operations team has successfully executed complex validation projects across 15 countries this year. With our recent ISO 9001:2015 certification, our processes are more streamlined than ever.
Innovation in CQV
Looking Ahead
Join us at our upcoming roadshows and webinars as we delve deeper into continuous compliance and the evolution of digital validation platforms.